文献速递胸部肿瘤

恶性胸膜间皮瘤的综合分子特征

Integrative Molecular Characterization of Malignant Pleural Mesothelioma.
PubMed 文献 · Cancer Discov · 2018-10-15

该研究对74例恶性胸膜间皮瘤(MPM)进行综合基因组分析,包括迄今最详细的BAP1改变分析。研究识别了不依赖组织学的分子预后亚群,定义了伴TP53和SETDB1突变及广泛杂合性丢失的新基因组亚型,并发现上皮样MPM中免疫检查点基因VISTA强表达。

要点

  • 识别了不依赖组织学的分子预后亚群。
  • 定义了伴TP53和SETDB1突变及广泛杂合性丢失的新基因组亚型。
  • 上皮样MPM中VISTA表达显著高于其他实体瘤。

核心结论

  • MPM存在不依赖组织学的分子预后亚群。
  • 存在伴TP53和SETDB1突变及广泛杂合性丢失的新基因组亚型。
  • 上皮样MPM中VISTA表达显著高于其他实体瘤。

研究设计与样本

  • 对74例MPM进行综合整合基因组研究。
  • 包含迄今最详细的BAP1改变分析。

主要发现

  • 识别了不依赖组织学的分子预后亚群。
  • 定义了伴TP53和SETDB1突变及广泛杂合性丢失的新基因组亚型。
  • 上皮样MPM中VISTA表达强,显著高于其他实体瘤。

临床怎么用

  • VISTA强表达对MPM免疫治疗有潜在意义。
  • 新基因组亚型为MPM治疗提供新方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Malignant pleural mesothelioma (MPM) is a highly lethal cancer of the lining of the chest cavity. To expand our understanding of MPM, we conducted a comprehensive integrated genomic study, including the most detailed analysis of BAP1 alterations to date. We identified histology-independent molecular prognostic subsets, and defined a novel genomic subtype with TP53 and SETDB1 mutations and extensive loss of heterozygosity. We also report strong expression of the immune-checkpoint gene VISTA in epithelioid MPM, strikingly higher than in other solid cancers, with implications for the immune response to MPM and for its immunotherapy. Our findings highlight new avenues for further investigation of MPM biology and novel therapeutic options. SIGNIFICANCE: Through a comprehensive integrated genomic study of 74 MPMs, we provide a deeper understanding of histology-independent determinants of aggressive behavior, define a novel genomic subtype with TP53 and SETDB1 mutations and extensive loss of heterozygosity, and discovered strong expression of the immune-checkpoint gene VISTA in epithelioid MPM.See related commentary by Aggarwal and Albelda, p. 1508.This article is highlighted in the In This Issue feature, p. 1494.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Hmeljak J, Sanchez-Vega F, Hoadley KA, et al. Integrative Molecular Characterization of Malignant Pleural Mesothelioma. Cancer Discov. 2018. PMID: 30322867. doi:10.1158/2159-8290.CD-18-0804

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。